Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06778954
NA

Ropivacaine-Poloxamer 407 Gel for Pain Control After Open Gastrectomy

Sponsor: Gangnam Severance Hospital

View on ClinicalTrials.gov

Summary

The study evaluates the efficacy of Ropivacaine-Poloxamer 407 hydrogel in reducing postoperative pain following open gastrectomy.

Official title: Prospective Randomized Controlled Trial of Ropivacaine-Poloxamer 407 Based Gel Application on Postoperative Pain After Open Gastrectomy

Key Details

Gender

All

Age Range

20 Years - Any

Study Type

INTERVENTIONAL

Enrollment

48

Start Date

2025-01-30

Completion Date

2025-12-31

Last Updated

2025-02-14

Healthy Volunteers

No

Conditions

Interventions

PROCEDURE

Arm I (Peritoneal application group)

At the end of gastrectomy, during closure of incision, peritoneum and fascia are closed by suture, layer by layer. Skin approximation is doen with skin stapler. Ropivacaine-Poloxamer 407 hydrogel is applied on space between peritoneum and fascia in Arm I.

PROCEDURE

Arm II (Subcutaneous injection group)

At the end of gastrectomy, during closure of incision, peritoneum and fascia are closed by suture, layer by layer. Skin approximation is doen with skin stapler. Ropivacaine-Poloxamer 407 hydrogel is injected on subcutaneous area in Arm II.

Locations (1)

GangnamSeverance Hospital

Seoul, South Korea